BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 2, 2020
View Archived Issues
Ditching PAMs expands CRISPR
Read More
In blood stem cells, selection drives driver mutations early on
Read More
FDA accepts IND application for OTQ-923
Read More
Johnson & Johnson announces new lead COVID-19 vaccine candidate
Read More
Positive phase II data for THN-102 in patients with Parkinson's disease and EDS
Read More
DSR-141562 shows promise in preclinical schizophrenia-related behavioral assays
Read More
DIF-1 shows antimetastatic effects in malignant melanoma cells
Read More
CRMP2 as a novel biomarker for schizophrenia
Read More
Researchers mimic interstitial cystitis in rat model
Read More
Biochemical Agent describes IGF-1 long chimeric proteins
Read More
New potent and selective ATP-competitive mTOR inhibitor with brain penetrance for CNS disorders
Read More
Ohio State University patents lipid nanoparticles modulating Bcl-2, Akt-1
Read More
Novel series of sulfamoylbenzamides modulating capsid assembly to target hepatitis B virus infection
Read More
Yale University, Arvinas Operations disclose new PROTAC compounds
Read More
Primmune selects PRTX-007 for development for SARS-CoV-2 prophylaxis
Read More
New RIP-1 inhibitors identified at Bristol-Myers Squibb
Read More
FORMA Therapeutics identifies new pyruvate kinase PKLR activators
Read More
Accelerated by COVID-19, science changes will outlast pandemic
Read More
Step-1 primary endpoint met in phase III Atalante 1 trial of Tedopi in NSCLC
Read More
FDA approves Sevenfact for hemophilia A and B
Read More
Nicotinic acetylcholine receptors as potential target for treating synucleinopathies
Read More
Interim analysis from study of siltuximab in patients with COVID-19 and respiratory complications
Read More
Arena reports topline phase I data on controlled-release etrasimod
Read More